DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $964 | -99.9% | 3,861 | +25.8% | 0.08% | +46.3% |
| Q4 2023 | $709,804 | -5.6% | 3,068 | +1.2% | 0.05% | -58.5% |
| Q3 2023 | $752,159 | +60852.9% | 3,032 | -41.0% | 0.13% | +19.3% |
| Q2 2023 | $1,234 | -0.9% | 5,142 | +4.1% | 0.11% | +7.9% |
| Q1 2023 | $1,245 | -100.0% | 4,940 | -4.3% | 0.10% | -15.8% |
| Q4 2022 | $1,369,893,140 | +101750.8% | 5,161 | -0.9% | 0.12% | -9.1% |
| Q3 2022 | $1,345,000 | +164.2% | 5,207 | +159.6% | 0.13% | +158.8% |
| Q2 2022 | $509,000 | -6.4% | 2,006 | +8.3% | 0.05% | +10.9% |
| Q1 2022 | $544,000 | -16.4% | 1,853 | -9.0% | 0.05% | -17.9% |
| Q4 2021 | $651,000 | +8.9% | 2,036 | +3.7% | 0.06% | -15.2% |
| Q3 2021 | $598,000 | +60.3% | 1,963 | +2.8% | 0.07% | +26.9% |
| Q2 2021 | $373,000 | -17.5% | 1,910 | -5.0% | 0.05% | -10.3% |
| Q1 2021 | $452,000 | +0.9% | 2,010 | -0.1% | 0.06% | -7.9% |
| Q4 2020 | $448,000 | -72.3% | 2,012 | -73.6% | 0.06% | -74.2% |
| Q3 2020 | $1,620,000 | +18.8% | 7,623 | -1.2% | 0.24% | +3.4% |
| Q2 2020 | $1,364,000 | +22.6% | 7,712 | -4.1% | 0.24% | +7.8% |
| Q1 2020 | $1,113,000 | -14.5% | 8,042 | -5.1% | 0.22% | -3.1% |
| Q4 2019 | $1,301,000 | +4.0% | 8,478 | -2.2% | 0.23% | -5.4% |
| Q3 2019 | $1,251,000 | -4.3% | 8,665 | -5.2% | 0.24% | -5.9% |
| Q2 2019 | $1,307,000 | +8.0% | 9,142 | -0.3% | 0.25% | +0.8% |
| Q1 2019 | $1,210,000 | +92.4% | 9,169 | +50.3% | 0.25% | +64.7% |
| Q4 2018 | $629,000 | +75.2% | 6,102 | +84.5% | 0.15% | +91.2% |
| Q3 2018 | $359,000 | +19.7% | 3,308 | +8.9% | 0.08% | +11.1% |
| Q2 2018 | $300,000 | +25.5% | 3,038 | +24.6% | 0.07% | -8.9% |
| Q1 2018 | $239,000 | +5.8% | 2,438 | 0.0% | 0.08% | +6.8% |
| Q4 2017 | $226,000 | +8.1% | 2,438 | 0.0% | 0.07% | -10.8% |
| Q3 2017 | $209,000 | +1.5% | 2,438 | -0.1% | 0.08% | -11.7% |
| Q2 2017 | $206,000 | -1.4% | 2,440 | 0.0% | 0.09% | +3.3% |
| Q1 2017 | $209,000 | -7.9% | 2,440 | -16.3% | 0.09% | -13.3% |
| Q4 2016 | $227,000 | -10.3% | 2,915 | -9.6% | 0.10% | -27.6% |
| Q3 2016 | $253,000 | -22.4% | 3,223 | 0.0% | 0.14% | -29.3% |
| Q2 2016 | $326,000 | -3.0% | 3,223 | -9.0% | 0.20% | +2.0% |
| Q1 2016 | $336,000 | +33.3% | 3,543 | +20.0% | 0.20% | +2.0% |
| Q3 2015 | $252,000 | -8.0% | 2,953 | -7.8% | 0.20% | +6.5% |
| Q2 2015 | $274,000 | -11.3% | 3,203 | -12.0% | 0.18% | -7.0% |
| Q1 2015 | $309,000 | +41.1% | 3,638 | +42.3% | 0.20% | +28.4% |
| Q4 2014 | $219,000 | -1.4% | 2,557 | -12.3% | 0.16% | -7.7% |
| Q3 2014 | $222,000 | -25.3% | 2,917 | -22.6% | 0.17% | -27.3% |
| Q2 2014 | $297,000 | -21.0% | 3,767 | -24.8% | 0.23% | -33.8% |
| Q1 2014 | $376,000 | +20.9% | 5,012 | +24.4% | 0.35% | +13.7% |
| Q4 2013 | $311,000 | – | 4,028 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |